Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...

ORIC Pharmaceuticals Inc. (NASDAQ: ORIC) shares rose 12% following a recommendation from Cantor Fitzgerald to buy shares amid a possible leak of encouraging clinical trial data. Analyst Prakhar ...

Cantor Fitzgerald notes that the firm discovered “what appears” to be an “accidental release” of a snippet on the ASCO-GU daily news website ...

A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating.

Toni Fitzgerald is a Pennsylvania-based reporter who has covered the media industry since 2002. She currently focuses her coverage on streaming and book publishing. She also works as a freelance ...

A slew of space stocks have skyrocketed following the inauguration of President Trump, boosted by his vow to champion American space exploration during his administration. Set against this ...

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for ORIC Pharmaceuticals in a report ...

Palantir Technologies Inc. (NASDAQ:PLTR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Palantir Technologies in a note issued to ...

We recently compiled a list of the Top 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against the other ...